Combination Therapy of Losartan and Fisetin Reduces Senescence and Enhances Osteogenesis in Human Bone Marrow–Derived Mesenchymal Stem Cells.

Home / Publications / Combination Therapy of Losartan and Fisetin Reduces Senescence and Enhances Osteogenesis in Human Bone Marrow–Derived Mesenchymal Stem Cells.

Haruki Nishimura, Yoichi Murata, Michael T. Mullen, Kohei Yamaura, Jacob Singer, Charles Huard, Dane R. G. Lind, William S. Hambright, Chelsea S. Bahney, Marc J. Philippon, Johnny Huard. Combination Therapy of Losartan and Fisetin Reduces Senescence and Enhances Osteogenesis in Human Bone Marrow–Derived Mesenchymal Stem Cells. Journal of Tissue Engineering and Regenerative Medicine. 2025 Jan 1; 2025(1).

2025
https://researcherprofiles.org/profile/602844893

Haruki Nishimura, Yoichi Murata, Michael T. Mullen, Kohei Yamaura, Jacob Singer, Charles Huard, Dane R. G. Lind, William S. Hambright, Chelsea S. Bahney, Marc J. Philippon, Johnny Huard

Support Engineering Innovations at UCSF